This study investigated possible growth-inhibiting effects of bee venom applied alone or in combination with a cytotoxic drug bleomycin on HeLa and V79 cells in vitro based on clone formation, cell counting, and apoptosis. Melittin, the key component of bee venom, is a potent inhibitor of calmodulin activity, and also a potent inhibitor cell growth and clonogenicity. Intracellular accumulation of melittin correlates with the cytotoxicity of antitumour agents. Previous studies indicated that some calcium antagonists and calmodulin inhibitors enhanced intracellular levels of antitumor agents by inhibiting their outward transport. In this study, treatment of exponentially growing HeLa and V79 cells with bleomycin caused a dose-dependent decrease in cell survival due to DNA damage. This lethal effect was potentiated by adding a non-lethal dose of the bee venom. By preventing repair of damaged DNA, bee venom inhibited recovery from potentially lethal damage induced by bleomycin in V79 and HeLa cells. Apoptosis, necrosis, and lysis were presumed as possible mechanisms by which bee venom inhibited growth and clonogenicity of V79 cells. HeLa cells, on the other hand, showed greater resistance to bee venom. Our fi ndings suggest that bee venom might fi nd a therapeutic use in enhancing cytotoxicity of antitumour agent bleomycin.
Many studies have reported about natural products inhibiting tumour cell growth and metastasis, as well as inducing apoptosis, bringing hope of improved treatment of human tumours (1) (2) (3) (4) (5) . Bee venom has traditionally been used to relieve pain and to treat chronic infl ammatory diseases such as rheumatoid arthritis. It has also been used by oriental traditional medicine (6) , and in recent times in the treatment of tumours (1) (2) (3) (4) 7) .
Bee venom plays a major role in the defence of bee colonies. It is produced in the venom gland of the bee, located in the abdominal cavity. It is a very complex mixture of active peptides, enzymes, and amines that contains histamine, catecholamines, polyamines, melittin, and phospholipase A 2 (7) (8) (9) (10) . The key component of bee venom is melittin, which makes 50 % of its dry weight. It is a strong basic polypeptide whose sequence consists of 26 amino acids (molecular weight 2850 Da) (7) (8) (9) (10) . It has strong haemolytic and cardiotoxic properties (7, 11, 12) and has been shown to revert the phenotype of H-ras-transformed cells (13) . Hait et al. demonstrated that melittin was one of the most potent inhibitors of calmodulin activity and a more potent inhibitor of cell growth and clonogenicity than phenothiazines. (14) (15) (16) (17) . Drugs that inhibit calmodulin activity have been shown to inhibit DNA synthesis in the glioblastoma cell line (18) , block the movement of chromosomes during metaphase (19) , inhibit the growth of Chinese hamster ovary cells (20) , and enhance the cytotoxicity of vincristine, doxorubicin, and bleomycin (21) (22) (23) . Evidence also suggests that calmodulin inhibitors are cytotoxic to malignant cells both in vitro (14, 24) and in vivo (1, 2, 25, 26) . In addition, bee venom induces single-and double-strand DNA breaks in human lymphocytes (27) .
In this study we investigated the effects of bee venom on the growth and clonogenicity HeLa and V79 cells. We also considered possible use of bee venom in enhancing the cytotoxicity of antitumour agents.
MATERIALS AND METHODS

Bee venom
Lyophilised whole bee venom was purchased from Medex (Ljubljana, Slovenia). It was reconstituted in 0.5 mL of distilled water and centrifuged at 12,000 rpm for 10 min to remove insoluble materials. The resulting solutions were administered to cell cultures in concentrations 0.7125 µg mL according to design described below.
Bleomycin
Bleomycin formulated for clinical use was obtained from Heinrich Mack Nachf (Illertissen, Germany). It was used at doses of 25 µg mL -1 , 50 µg mL -1 or 100 µg mL -1 . Unless specified otherwise, the rest of the chemicals and reagents used were purchased form Sigma Chemical Co (St. Louis, USA).
Cell lines
The experiments were performed on human cervical carcinoma cells (HeLa) and Chinese hamster lung fi broblasts (V79). The average doubling time in log phase was about 20 h for HeLa cells and 12 h for V79 cells. Cells were grown in monolayer cultures in plastic disposable Petri dishes (Falcon) in minimal essential medium supplemented with 10 % foetal calf serum. Cell cultures were incubated at 37 °C in humid atmosphere containing 5 % CO 2 in air.
Cell counting
Cells were counted using Coulter Counter (Model B, Coulter Electronics, Dunstable, England). Petri dishes with different concentrations of the studied compounds were incubated for 72 h. Growth medium was then removed, and cells rinsed with phosphatebuffered saline (PBS), trypsinised, diluted, and counted in triplicate.
Colony formation
Exponentially growing HeLa and V79 cells were treated with various concentrations of bee venom for 24 h. After treatment, the bee venom was removed, and the cultures washed twice with PBS. Cells were trypsinised, and their survival determined by colony formation as described elsewhere (20) . Cells were immediately plated on culture dishes in triplicate and propagated in culture for 8 to 10 days to evaluate the ability of the treated cells to form colonies. Colonies were stained with 10 % Giemsa and counted. A cell was considered to have retained reproductive capacity (survival) if it gave rise to a colony of 50 or more cells. The results were expressed as percent of colonies of untreated cells. The plating effi ciency of the untreated control culture was 65 %.
Survival studies for simultaneous treatment with bleomycin and bee venom
Exponentially growing HeLa and V79 cells were treated for 1 h with various concentrations of bleomycin alone (25 µg mL -1 to 100 µg mL -1 ) dissolved in fresh medium or with bleomycin in combination with bee venom. After treatment, both compounds were removed, and cultures washed twice with PBS. Cells were trypsinised, and survival determined by colony formation (20) . Cells were then counted and seeded into Petri dishes (100 cells per dish). After 10 days, the medium was removed and cells stained with 10 % Giemsa. Colonies containing 50 cells or more were scored and results expressed as the survival index. The index was calculated by dividing the number of colonies formed per plate by the total number of singe cells initially seeded per plate.
Effect of bee venom on recovery from bleomycin-induced cell damage
Exponentially growing cells were treated with bleomycin (100 µg mL -1 ) for 1 h. The drug was then removed and cultures washed twice with PBS. One group of cells was immediately processed for colony formation, with no time allowed for recovery. Replicate plates were treated with fresh medium alone or fresh medium containing bee venom in various concentrations. The cultures were then incubated at 37 °C and allowed to recover for 3 h. At appropriate times, replicate plates were removed and prepared for colony formation. Cell survival was determined as described above.
Apoptosis analysis
Apoptosis was determined using bivariant fl ow cytometry (28) on cells that were grown in the presence or absence of bee venom for 3 h or 15 h , respectively. The cells were washed in cold PBS twice and resuspended in a small volume of 1x binding buffer (HEPES containing 2.5 mmol L -1 CaCl 2 ). Fluorescein-labelled annexin V and propidium iodide (PI) were added to the cells, which were then analysed using fl ow cytometry.
Staining with PI allowed for determination of DNA content in the tested cells. For that purpose, the cells were incubated in 100 µL of fi xing solution at 4 °C for 15 min, washed in PBS, resuspended in permeabilising solution in the presence of 10 µL of PI, and incubated at 4 °C for 15 min. The cells were then washed with PBS and immediately analysed using fl ow cytometry.
Statistics
Results are expressed as means ± SE obtained from two or three experiments in triplicate. Statistical signifi cance was evaluated using the Student's t-test.
RESULTS
Bee venom cytotoxicity
Growth inhibitory effect of bee venom administered in various concentrations to HeLa and V79 cells was estimated by counting their number after 72 h of treatment. Figure 1 shows the infl uence of bee venom on the growth of the tested cells.
Growth inhibition by bee venom was dosedependent in both cell lines. IC 50 for HeLa cells was 3 µg mL -1 . The inhibitory effect on V79 cells was more pronounced, and the same dose of bee venom killed about 90 % of V79 cells.
As for colony-forming, V79 cells treated in exponentially growing phase were more sensitive to the adverse effects of bee venom administered for 24 h than HeLa cells (Figure 2) .
Potentiation of bleomycin lethality by bee venom
Treatment of exponentially growing cells with the DNA damaging agent bleomycin caused a dosedependent decrease in cell survival. This lethal effect was potentiated by a nonlethal dose (2.85 µg mL -1 ) of bee venom (Figure 3 ). Bee venom enhanced toxic effects of bleomycin (25 µg mL -1 to 100 µg mL -1 ) on HeLa cells from 27 % to 58 %. In presence of bee venom, 55 % of the V79 cells were killed at bleomycin dose of 25 µg mL -1 , and increasing the dose of bleomycin to 100 µg mL -1 resulted in a further 79 % decrease in cell survival. Figure 4 shows how bee venom affected recovery from bleomycin-induced damage based on increased survival observed when cells were exposed to various concentrations of bee venom after a single exposure to a bleomycin. HeLa and V79 cells were recovering in a fresh medium, and the addition of bee venom to the medium at concentrations of 0.7125 µg mL -1 , 1.425 µg mL -1 , or 2.85 µg mL -1 not only inhibited recovery, but also resulted in a signifi cant increase Figure  4 ).
Effect of bee venom on recovery from bleomycin-induced damage
Apoptosis and necrosis assay
The effect of bee venom (1.425 µg mL -1 or 2.25 µg mL -1 ) on HeLa cells that were treated for 3 h or 15 h was evaluated using fl ow cytometry ( Figure  5 ). Early stage of apoptosis started three hours after the treatment of HeLa cells with bee venom. In control HeLa cells early stage apoptosis was recorded for 2.15 % of cells, whereas in the culture treated with 1.425 µg mL -1 of bee venom for three hours it was recorded for 6.18 % of cells. Apoptosis in HeLa cells treated with bee venom for 15 h was 7.79 % versus 4.09 % in the control line. We also observed a slight increase in the number of necrotic cells both after 3 h and 15 h of HeLa cell incubation with bee venom. Early stage apoptosis and necrosis of V79 cells was not determined. Instead, we determined the percentage of cells in A 0 , which is an indicator of late apoptosis ( Figure 6 ). Apoptosis in V79 cells treated with 1.425 µg mL -1 of bee venom for 3 h was 13.14 % versus 5.6 % in the control line, while apoptosis in V79 cells treated for 15 h was lower than control ( Figure 6 ).
DISCUSSION
The results of our study provide an additional support to previous reports on antitumour activity of melittin in vitro (1, 4, (15) (16) (17) . Melittin was a more potent inhibitor of calmodulin activity and growth of L1210 cells, C6 astrocytoma, and human and murine leukaemic cells than trifl uoperazine or chlorpromazine. Weiss et al. (29, 30) demonstrated that phenothiazines and structurally similar drugs were binding to and inhibiting calmodulin activity.
Our study shows that bee venom inhibits cell growth, cell proliferation, and clonogenicity of V79 and HeLa cells, possibly through inhibition of calmodulin (Figures 1 and 2) . Our results suggest that V79 cells are more sensitive to calmodulin inhibitors and the lytic effect of bee venom than HeLa cells. This effect may be owed to differences in average doubling time in the log phase between V79 and HeLa cells (12 h for V79 cells and about 20 h for HeLa cells), differences in membrane topography, and differences Time / h in cell calcium and magnesium levels. In addition, V79 cells are rich in amino-group/carbohydrate binding sites, which also bind melittin (31) .
Figure 4 Effect of bee venom on recovery from bleomycin-induced damage. Exponentially growing V79 and
We also observed differences in the growth curves of HeLa and V79 cells treated with bee venom. Since the number of cells in a culture is a measure of both cell proliferation and death, growth inhibition by calmodulin inhibitors could be due to the inhibition of proliferation rather than to cytotoxicity, which is in line with our results. Balk et al. (32) strongly suggest that both calcium and magnesium play signifi cant roles in triggering cell replication. However, other evidence indicates that extracellular calcium is necessary for DNA synthesis and cell proliferation in normal cells, but not in cancer cells (33) .
The mechanism by which bee venom exerts anticalmodulin activity and inhibits cell growth is unknown. One possible mechanism might be the inhibition of a calmodulin-sensitive enzyme such as cyclic nucleotide phosphodiesterase. Inhibition appears to be mediated by the formation of a calcium-dependent high-affi nity complex of calmodulin and melittin (34) (35) (36) (37) . Although phosphodiesterase was the fi rst enzyme demonstrated to be activated by calmodulin, it is now known that numerous enzymes and structural proteins depend on this pervasive calcium-binding protein (38, 39) . Calmodulin is essential for many processes in normal cell function, including the assembly and disassembly of microtubules, calcium extrusion from cells by a calcium-magnesium ATPase, and activation of numerous intracellular enzymes such as protein kinases, phosphatases, and cyclic nucleotide phosphodiesterase (38, 39) . Interference with any of these known functions of calmodulin could be toxic to cells. Other cell functions affected by calmodulin inhibitors may or may not be mediated exclusively by calmodulin inhibition. These effects include depletion of intracellular ATP (40), destabilisation of the membranes (1, 10, 13, 14) , and inhibition of protein kinase C.
Our data indicate that bee venom inhibits DNA repair and that this may be the mechanism by which it increases bleomycin lethality and inhibits recovery from bleomycin-induced damage (Figures 3 and 4) . Several mechanisms may explain our fi ndings. Firstly, effl ux of antitumor agents from cells may be controlled by calcium and calmodulin (calcium-calmodulin complex), and calmodulin inhibitors could directly inhibit the calcium-calmodulin complex. Secondly, permeability of cell membranes might be perturbed by bee venom or by changes in calcium environment. Thirdly, the affi nity of bleomycin for intracellular targets may be altered by calcium antagonist-induced changes in calcium environment or by calmodulin inhibitors.
In this study, we have shown that bee venom might result in apoptosis and/or necrosis of HeLa and V79 cells. Bee venom caused dose-and time-dependent changes in V79 cells, but not in HeLa cells (Figures 5  and 6 ). The absence of apoptosis or necrosis in HeLa cells remains unexplained, and calls for a long-term study with bee venom. It is also possible that melittin as a Ca 2+ antagonist also blocks the Ca 2+ channel, and offers complete protection against cell death. In (43) (44) (45) . Although these reports argue that Ca 2+ /Mg 2+ endonuclease fragmentation of DNA may not always be involved in apoptosis, and that, when present, it may be a relatively late molecular event, they did not dismiss other forms of DNA damage, such as detachment of duplex DNA loops from the nuclear scaffold and the cleavage of DNA into large kilobase and megabase fragments, as important early events in the stereotype changes in DNA morphology. Although the role of Ca 2+ in early chromatin disruption is ambiguous, DNA damage remains the leading candidate for initiating apoptotic cell death.
The underlying mechanisms of apoptosis are largely unknown. A recent study by Tu et al. (46) demonstrated anticancer effects of bee venom in human melanoma A2058 cells and its mode of action at the cellular and molecular levels. The authors found that honeybee venom induced calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells, but not in normal skin fi broblast Detroit 551 cells. They suggested that treatment of A2058 cells with melittin, the key component of bee venom, resulted in similar elevation of calcium levels and cell death (47) . Observations by Ip et al. (48) indicated that bee venom induced cell cycle arrest and apoptosis in human cervical epidermoid carcinoma Ca Ski cells via a Fas receptor pathway, involving mitochondrial-dependent pathways, and that it is closely related to the level of cytoplasmic Ca 2+ in Ca Ski cells. Flow cytometry in their study showed that bee venom induced reactive oxygen species, increased the level of cytoplasmic Ca 2+ , reduced mitochondrial membrane potential which led to cytochrome c release, and promoted the activation of caspase-3 which then led to apoptosis. Bee venom also induced an increase in the levels of Fas, p53, p21 and Bax, but a decrease in the level of Bcl-2. The activities of both caspase-8 and caspase-9 were enhanced by bee venom, promoting caspase-3 activation and leading to DNA fragmentation. Apart from the caspase-dependent pathway, these authors also suggested a caspase-independent pathway through expression of apoptosis-inducing factor (AIF) and endonuclease G (Endo G) in the Ca Ski cells. A similar mechanism of bee venom was confi rmed in human breast cancer MCF7 cells (49) , U937 cells (50) , and in human MG63 osteosarcoma cells (47) . Data by Wang et al. (51) suggest that melittin can synergize with TRAIL in the induction of human hepatocellular carcinoma cell (HCC) apoptosis, and that the combination of melittin with tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) may be a promising therapeutic approach in the treatment of TRAIL-resistant human cancer.
In summary, this study suggests that proliferation and clonogenicity of V79 and HeLa cells in culture with the bee venom is not entirely due to the inhibition of calmodulin, and that the cytotoxic effect of bee venom could partially be related to its apoptotic and necrotic activities. This study also points to possible new ways to use bee venom to improve the cytotoxic effects of antitumour, calmodulin-inhibiting agents.
